Metabolic & diet

Weight, blood sugar, and diet examined through the actual data on GLP-1s, red meat, protein, and continuous glucose monitoring.

September 10, 2026

Canola, soybean, and corn oil are accused of causing inflammation, obesity, and worse. Here's what the randomized trials and biobank data actually show.

September 3, 2026

How often should you poop, does transit time matter, do squatty potties work, and is a microbiome test worth $400? A doctor walks through the actual evidence.

August 6, 2026

Celiac disease, wheat allergy, and non-celiac gluten sensitivity, sorted out. What blinded challenge trials show about who really reacts to gluten, and who doesn't.

July 23, 2026

The evidence on light to moderate drinking, from cancer and heart disease to sleep, and why most warnings about a single glass rest on weak data.

May 28, 2026

A nephrologist breaks down what the evidence on red meat, saturated fat, LDL, and cancer risk actually says, and where the science gets oversold.

April 16, 2026

A nephrologist breaks down whether continuous glucose monitors help non-diabetics, what the evidence shows on spikes, and when a CGM is worth $50.

April 9, 2026

A Yale nephrologist breaks down the evidence on protein intake: how much you need, what it does for muscle and weight loss, and when more is too much.

March 5, 2026

A nephrologist's honest look at GLP-1 drugs like Ozempic and Zepbound: weight loss, muscle loss, weight regain, side effects, and what we still don't know.

All topics  ·  All articles

F. Perry Wilson, MD MSCE

About the author

F. Perry Wilson, MD MSCE is a nephrologist, clinical researcher, and Associate Professor of Medicine and Public Health at Yale University, where he directs the Clinical and Translational Research Accelerator. He hosts the Wellness, Actually podcast with Emily Oster, writes the weekly Impact Factor column on Medscape, and is the author of How Medicine Works and When It Doesn't (Grand Central, 2023).

More about Dr. Wilson  ·  Google Scholar  ·  PubMed